openalexFrontiers in Oncology2026-07-23
Editorial: Liquid biopsy in non-small cell lung cancer for diagnosis, treatment selection and monitoring
A. Strati, Benoît Roch, Ammar Sukari
Lung cancer is the third most common malignancy in the United States and remains the leading cause of cancer-related mortality worldwide. Despite ongoing advances in diagnosis and therapy, survival rates for patients with lung cancer remain unsatisfactory (1). In recent years, in…